C6K Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.488 EUR 3.15% Market Closed

Market Cap: €238.9m

	Avalo Therapeutics Inc F:C6K	US
P	Pepkor Holdings Ltd JSE:PPH	ZA
	Indoritel Makmur Internasional Tbk PT IDX:DNET	ID
D	Danieli & C Officine Meccaniche SpA XBER:DAS	IT
	Azienda Bresciana Petroli Nocivelli SpA F:9UZ	IT
	Arverne Group SA PAR:ARVEN	FR
C	Chasys Co Ltd KRX:033250	KR
	Costco Wholesale Corp NASDAQ:COST	US
C	Conagra Brands Inc DUS:CAO	US
C	CombinedX AB (publ) STO:CX	SE
A	Air Canada SWB:ADH2	CA
	Lion Electric Co F:70U	CA

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

105%

Gross Margin is Increasing

86% > 100%

Negative Operating Margin

-123.602%

Negative 3Y Average Operating Margin

-18.716%

Declining Operating Margin

-122% > -123.602%

Negative Net Margin

-132.642%

Negative 3Y Average Net Margin

-21.305%

Declining Net Margin

-146% > -132.642%

Negative Free Cash Flow Margin

-87.217%

Negative 3Y Average Free Cash Flow Margin

-14.686%

Declining Free Cash Flow Margin

-115% > -87.217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-281%

Declining ROIC

-115% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.